Edition:
United Kingdom

Agile Therapeutics Inc (AGRX.OQ)

AGRX.OQ on NASDAQ Stock Exchange Capital Market

1.12USD
16 Aug 2019
Change (% chg)

-- (--)
Prev Close
$1.12
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
48,477
52-wk High
$1.70
52-wk Low
$0.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.125
FY 2018 Dec '18 0.00 -0.111
Sep '18 0.00 -0.110
Jun '18 0.00 -0.156
Mar '18 0.00 -0.200
FY 2017 Dec '17 0.00 -0.182
Sep '17 0.00 -0.222
Jun '17 0.00 -0.259
Mar '17 0.00 -0.261
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 6 0.00 0.00 0.00 --
Quarter Ending Dec-19 6 0.00 0.00 0.00 --
Year Ending Dec-19 6 0.00 0.00 0.00 10.62
Year Ending Dec-20 6 21.48 38.40 5.03 62.11
Earnings (per share)
Quarter Ending Sep-19 6 -0.11 -0.08 -0.14 --
Quarter Ending Dec-19 6 -0.10 -0.06 -0.14 --
Year Ending Dec-19 6 -0.44 -0.34 -0.52 -0.79
Year Ending Dec-20 6 -0.33 0.11 -0.85 -0.47
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 98.31 33.85
P/E High - Last 5 Yrs. -- 169.52 54.29
P/E Low - Last 5 Yrs. -- 53.54 28.22
Beta 0.52 1.29 0.99
Price to Sales (TTM) -- 42.65 7.90
Price to Book (MRQ) 2.21 12.25 4.38
Price to Tangible Book (MRQ) 2.22 17.14 5.07
Price to Cash Flow (TTM) -- 64.56 23.70
% Owned Institutions 55.29 3.24 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.67
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.86 6.82
Payout Ratio(TTM) -- 2.55 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 53.93 14.65
Sales (TTM) vs TTM 1 Yr. Ago -- 51.52 8.45
Sales - 5 Yr. Growth Rate -- 33.42 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago 37.31 -8.31 19.40
EPS (TTM) vs TTM 1 Yr. Ago 41.80 -- --
EPS - 5 Yr. Growth Rate -- 22.74 7.15
Capital Spending - 5 Yr. Growth Rate -42.24 26.66 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.76 2.52
Current Ratio (MRQ) 8.91 3.87 3.52
LT Debt to Equity (MRQ) 0.00 7.63 12.61
Total Debt to Equity (MRQ) 0.00 20.26 17.64
Interest Coverage (TTM) -19.54 30.21 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 21.69 50.25
Gross Margin - 5 Yr. Avg. -- 58.96 51.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -12.49 16.42
Operating Margin (TTM) -- -124.67 -6.97
Operating Margin - 5 Yr. Avg. -- -28.74 11.87
Pre-Tax Margin (TTM) -- -126.48 -7.30
Pre-Tax Margin - 5 Yr. Avg. -- -34.06 15.72
Net Profit Margin (TTM) -- -132.21 -11.11
Net Profit Margin - 5 Yr. Avg. -- -38.92 11.11
Effective Tax Rate (TTM) -- 17.21 20.61
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 10,400,894 870,638,159
Net Income/Employee (TTM) -1,355,000 2,349,448 101,855,832
Receivable Turnover (TTM) -- 12.32 5.88
Inventory Turnover (TTM) -- 2.26 3.66
Asset Turnover (TTM) 0.00 0.32 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -51.02 6.26 10.25
Return on Assets - 5 Yr. Avg. -51.76 6.14 11.17
Return on Investment (TTM) -63.59 7.52 12.69
Return on Investment - 5 Yr. Avg. -64.33 7.98 14.15
Return on Equity (TTM) -63.74 7.94 17.13
Return on Equity - 5 Yr. Avg. -103.80 8.90 15.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 36.99 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Agile Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -10.96 -13.43 29 4
13 Week -13.33 -15.80 49 7
26 Week 53.12 34.85 87 20
52 Week 334.02 307.00 99 12
YTD 125.73 87.01 92 9
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 55.29%
# of Holders: 38
Total Shares Held: 24,186,340
3 Mo. Net Change: 1,039
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.